Rezultati - Jonathan Kay

Biosimilars in rheumatology: what the clinician should know od Jonathan Kay, Gilberto Castañeda-Hernández, Rodrigo González-Ramírez, Morton A Scheinberg

Polni tekst

Modeling the Effects of Formulary Exclusions: How Many Patients Could Be Affected by a Specific Exclusion? od Anne M. Sydor, Emily Bergin, Jonathan Kay, Erik Stone, Robert Popovian

Polni tekst

Comanagement with rheumatology and prescription biologics filled during pregnancy in women with rheumatic diseases: a retrospective analysis of US administrative claims data od Jonathan Kay, Kate L Lapane, Divya Shridharmurthy, Jonggyu Baek, Anthony Nunes, Shao-Hsien Liu

Polni tekst

Treatment Persistence and Switching Patterns of Adalimumab Biosimilar ABP 501 in European Patients with Rheumatologic Diseases od Ran Jin, Silvia Kruppert, Florian Scholz, Isabelle Bardoulat, Khalil Karzazi, Francois Morand, Greg Kricorian, David Collier, Jonathan Kay

Polni tekst

A new education agenda based on The International Science and Evidence Based Education Assessment od Nandini Chatterjee Singh, Tal Gilead, Anya Chakraborty, Jo Van Herwegen, Nienke van Atteveldt, Gregoire Borst, Stephanie Bugden, Kaja Jasinska, Jonathan Kay, Kenneth Pugh, Anantha Duraiappah

Polni tekst

Association of clinical response criteria and disease activity levels with axial spondyloarthritis core domains: results from two phase 3 randomised studies, BE MOBILE 1 and 2 od Sofia Ramiro, Atul Deodhar, Philip J Mease, Martin Rudwaleit, Jonathan Kay, Marina Magrey, Victoria Navarro-Compán, Vanessa Taieb, Carmen Fleurinck, Ute Massow, Michael F Mørup, Christine de la Loge

Polni tekst

Sustained improvements in spinal pain, morning stiffness, fatigue, sleep, physical function and overall health-related quality of life with bimekizumab in patients with axial spond... od Atul Deodhar, Philip J Mease, Martin Rudwaleit, Maria-Antonietta D’Agostino, Jonathan Kay, Karl Gaffney, Helena Marzo-Ortega, Marina Magrey, Maureen Dubreuil, Victoria Navarro-Compán, Vanessa Taieb, Ute Massow, Christine de la Loge, Tom Vaux

Polni tekst

Guselkumab versus golimumab in patients with active psoriatic arthritis and inadequate response to an initial tumor necrosis factor inhibitor: study protocol for EVOLUTION, a pragm... od Alexis Ogdie, Soumya M. Reddy, Sarah H. Gillespie, M. Elaine Husni, Jose U. Scher, Karen Salomon-Escoto, Jonathan Kay, Brent A. Luedders, Jeffrey R. Curtis, Alisa J. Stephens Shields, Soumya D. Chakravarty, Cinty Gong, Jessica A. Walsh

Polni tekst